Provided by Tiger Trade Technology Pte. Ltd.

Forte BioSciences Inc

76.92
+0.03000.04%
Volume:2.01M
Turnover:154.80M
Market Cap:1.63B
PE:-16.92
High:76.95
Open:76.94
Low:76.89
Close:76.89
52wk High:77.20
52wk Low:10.11
Shares:21.23M
Float Shares:19.00M
Volume Ratio:0.88
T/O Rate:10.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5455
EPS(LYR):-4.7137
ROE:-62.28%
ROA:-37.79%
PB:8.88
PE(LYR):-16.32

Loading ...

Forte Biosciences shareholders approve amended, restated 2021 equity incentive plan at annual meeting

Reuters
·
Jun 03

Forte Biosciences Slides As Insider Purchases Lose Another US$70k

Simply Wall St.
·
May 30

Forte Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

Forte Biosciences Inc expected to post a loss of $1.08 a share - Earnings Preview

Reuters
·
May 12

Forte Biosciences grants new hire options, RSUs covering 100,000 shares

Reuters
·
May 12

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

THOMSON REUTERS
·
May 12

Forte Biosciences Q1 EPS $(1.24) Misses $(1.19) Estimate

Benzinga Earnings
·
May 11

Forte Biosciences Q1 FY26 net loss widens to $22.14 million

Reuters
·
May 11

Forte Biosciences, Inc. Announces First Quarter 2026 Results and Provides Update

THOMSON REUTERS
·
May 11

Forte Biosciences Q1 Income From Operations USD -22.439 Million

THOMSON REUTERS
·
May 11

Top Midday Gainers

MT Newswires Live
·
Apr 10

BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman

Reuters
·
Apr 10

Forte Biosciences Up Nearly 33%, on Pace for Largest Percent Increase Since May 2025 -- Data Talk

Dow Jones
·
Apr 09

BRIEF-Forte Biosciences Announces Pricing Of $150 Million Public Offering

Reuters
·
Apr 09

Forte Biosciences Inc - Announces Pricing of 5,709,936 Share Public Offering at $26.27 per Share

THOMSON REUTERS
·
Apr 09

BUZZ-Forte Biosciences falls after launching stock offering

Reuters
·
Apr 09

Forte Biosciences launches underwritten public offering of common stock

Reuters
·
Apr 09

Forte Biosciences Announces Proposed Public Offering

THOMSON REUTERS
·
Apr 09

Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and Forte Biosciences (FBRX)

TIPRANKS
·
Apr 01

Forte Biosciences Q4 EPS $(1.45) Misses $(1.06) Estimate

Benzinga Earnings
·
Apr 01